PharmaShots | Incisive News in 3 Shots

Subscribe Now

Stuart Therapeutics

Stuart Therapeutics Reports First Patient, First Visit in the P-III Study of Vezocolmitide for Treating Dry Eye Disease

Stuart Therapeutics Reports First Patient, First Visit in the P-III Study of Vezocolmitide for Treating Dry Eye Disease

January 1, 2024

Stuart Therapeutics Entered into an Exclusive License Agreement with Glaukos Corporation to Develop the First Neuroprotective Therapy

Stuart Therapeutics Entered into an Exclusive License Agreement with Glaukos Corporation to Develop the First Neuroprotective Ther...

October 19, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us